raloxifene hydrochloride has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, Y; Jia, Z; Li, Z; Sun, L; Wang, G; Wang, H; Zhang, A | 1 |
| Attwood, KM; Balgi, AD; Brandman, DM; Castle, EL; Colp, P; Corcoran, JA; Croul, S; Kim, I; McCormick, C; Roberge, M; Robichaud, A; Weeks, A; Westhaver, LP | 1 |
2 other study(ies) available for raloxifene hydrochloride and Astrocytoma, Grade IV
| Article | Year |
|---|---|
The role of PKN1 in glioma pathogenesis and the antiglioma effect of raloxifene targeting PKN1.
Topics: Apoptosis; Cell Proliferation; Female; Glioblastoma; Glioma; Humans; Raloxifene Hydrochloride | 2023 |
Raloxifene prevents stress granule dissolution, impairs translational control and promotes cell death during hypoxia in glioblastoma cells.
Topics: Cell Death; Estrogen Antagonists; Glioblastoma; Humans; Raloxifene Hydrochloride | 2020 |